The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2011-12-21

AUTHORS

Guy A Higgins, Leo B Silenieks, Anne Roßmann, Zoe Rizos, Kevin Noble, Ashlie D Soko, Paul J Fletcher

ABSTRACT

Lorcaserin ((1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine HCl) is a selective 5-HT2C receptor agonist with clinical efficacy in phase-III obesity trials. Based on evidence that this drug class also affects behaviors motivated by drug reinforcement, we compared the effect of lorcaserin on behavior maintained by food and nicotine reinforcement, as well as the stimulant and discriminative stimulus properties of nicotine in the rat. Acutely administered lorcaserin (0.3–3 mg/kg, subcutaneous (SC)) dose dependently reduced feeding induced by 22-h food deprivation or palatability. Effects up to 1 mg/kg were consistent with a specific effect on feeding motivation. Lorcaserin (0.6–1 mg/kg, SC) reduced operant responding for food on progressive and fixed ratio schedules of reinforcement. In this dose range lorcaserin also reversed the motor stimulant effect of nicotine, reduced intravenous self-administration of nicotine, and attenuated the nicotine cue in rats trained to discriminate nicotine from saline. Lorcaserin also reduced the reinstatement of nicotine-seeking behavior elicited by a compound cue comprising a nicotine prime and conditioned stimulus previously paired with nicotine reinforcement. Lorcaserin did not reinstate nicotine-seeking behavior or substitute for a nicotine cue. Finally, lorcaserin (0.3–1 mg/kg) reduced nicotine-induced increases in anticipatory responding, a measure of impulsive action, in rats performing the five-choice serial reaction time task. Importantly, these results indicate that lorcaserin, and likely other selective 5-HT2C receptor agonists, similarly affect both food- and nicotine-motivated behaviors, and nicotine-induced impulsivity. Collectively, these findings highlight a therapeutic potential for 5-HT2C agonists such as lorcaserin beyond obesity into addictive behaviors, such as nicotine dependence. More... »

PAGES

1177-1191

References to SciGraph publications

  • 2002-08-09. The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry in PSYCHOPHARMACOLOGY
  • 1999-10. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers in PSYCHOPHARMACOLOGY
  • 2006-09-22. Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure in PSYCHOPHARMACOLOGY
  • 2010-06-02. Stimulation of Medial Prefrontal Cortex Serotonin 2C (5-HT2C) Receptors Attenuates Cocaine-Seeking Behavior in NEUROPSYCHOPHARMACOLOGY
  • 2009-03-25. 5-HT2A and 5-HT2C Receptors Exert Opposing Effects on Locomotor Activity in Mice in NEUROPSYCHOPHARMACOLOGY
  • 2009-12-05. The α4β2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats in PSYCHOPHARMACOLOGY
  • 2007-07-25. The 5-HT2C Receptor Agonist Ro60-0175 Reduces Cocaine Self-Administration and Reinstatement Induced by the Stressor Yohimbine, and Contextual Cues in NEUROPSYCHOPHARMACOLOGY
  • 2007-09-27. Stimulation of serotonin2C receptors influences cocaine-seeking behavior in response to drug-associated stimuli in rats in PSYCHOPHARMACOLOGY
  • 2002-10-26. The reinstatement model of drug relapse: history, methodology and major findings in PSYCHOPHARMACOLOGY
  • 2011-03-16. Evaluation of the Abuse Potential of Lorcaserin, a Serotonin 2C (5‐HT2C) Receptor Agonist, in Recreational Polydrug Users in CLINICAL PHARMACOLOGY & THERAPEUTICS
  • 2003-04-09. Dopaminergic and cholinergic involvement in the discriminative stimulus effects of nicotine and cocaine in rats in PSYCHOPHARMACOLOGY
  • 2007-08-03. Opposing effects of 5-HT2A and 5-HT2C receptor antagonists in the rat and mouse on premature responding in the five-choice serial reaction time test in PSYCHOPHARMACOLOGY
  • 2011-02-02. Nicotine-Mediated Activation of Dopaminergic Neurons in Distinct Regions of the Ventral Tegmental Area in NEUROPSYCHOPHARMACOLOGY
  • 2007-01. Serotonergic Drugs in DRUGS
  • 2011-04-19. Acute nicotine increases both impulsive choice and behavioural disinhibition in rats in PSYCHOPHARMACOLOGY
  • 1992-06. The mesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine in PSYCHOPHARMACOLOGY
  • 2001-07-25. Activation of 5-HT2C receptors reduces the locomotor and rewarding effects of nicotine in PSYCHOPHARMACOLOGY
  • 2007-05-01. The serotonin2C receptor agonist Ro-60-0175 attenuates effects of nicotine in the five-choice serial reaction time task and in drug discrimination in PSYCHOPHARMACOLOGY
  • 2000-08-19. Similarities in the action of Ro 60-0175, a 5-HT2C receptor agonist, and d-fenfluramine on feeding patterns in the rat in PSYCHOPHARMACOLOGY
  • 1999-04. Reduced satiating effect of d-fenfluramine in serotonin 5-HT2C receptor mutant mice in PSYCHOPHARMACOLOGY
  • 2005-04-26. How can drug addiction help us understand obesity? in NATURE NEUROSCIENCE
  • 2009. Recognising Nicotine: The Neurobiological Basis of Nicotine Discrimination in NICOTINE PSYCHOPHARMACOLOGY
  • 2005-04-26. Anatomy and regulation of the central melanocortin system in NATURE NEUROSCIENCE
  • Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1038/npp.2011.303

    DOI

    http://dx.doi.org/10.1038/npp.2011.303

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1038645859

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/22189292


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/17", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Psychology and Cognitive Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1701", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Psychology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aminopyridines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Analysis of Variance", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Animals", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Behavior, Animal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Benzazepines", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Choice Behavior", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Conditioning, Operant", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Discrimination, Psychological", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Dose-Response Relationship, Drug", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Drug Administration Routes", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Eating", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Feeding Behavior", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Impulsive Behavior", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Indoles", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Motor Activity", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nicotine", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Nicotinic Agonists", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rats, Sprague-Dawley", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reaction Time", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Reinforcement, Psychology", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Rotarod Performance Test", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Self Administration", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Serotonin Receptor Agonists", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department Pharmacology, University of Toronto, Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "InterVivo Solutions Inc., Toronto, ON, Canada", 
                "Department Pharmacology, University of Toronto, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Higgins", 
            "givenName": "Guy A", 
            "id": "sg:person.01347147473.36", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347147473.36"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "InterVivo Solutions Inc., Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "InterVivo Solutions Inc., Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Silenieks", 
            "givenName": "Leo B", 
            "id": "sg:person.01254103027.51", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254103027.51"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "InterVivo Solutions Inc., Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/None", 
              "name": [
                "InterVivo Solutions Inc., Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Ro\u00dfmann", 
            "givenName": "Anne", 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.155956.b", 
              "name": [
                "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Rizos", 
            "givenName": "Zoe", 
            "id": "sg:person.01147665155.39", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147665155.39"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.155956.b", 
              "name": [
                "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Noble", 
            "givenName": "Kevin", 
            "id": "sg:person.0761457167.61", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761457167.61"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.155956.b", 
              "name": [
                "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Soko", 
            "givenName": "Ashlie D", 
            "id": "sg:person.01075705567.20", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075705567.20"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department Psychiatry & Psychology, University of Toronto, Toronto, ON, Canada", 
              "id": "http://www.grid.ac/institutes/grid.17063.33", 
              "name": [
                "Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada", 
                "Department Psychiatry & Psychology, University of Toronto, Toronto, ON, Canada"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fletcher", 
            "givenName": "Paul J", 
            "id": "sg:person.07504427742.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07504427742.08"
            ], 
            "type": "Person"
          }
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1007/s00213-003-1426-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1014431196", 
              "https://doi.org/10.1007/s00213-003-1426-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130000504", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050140339", 
              "https://doi.org/10.1007/s002130000504"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nn1455", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052352207", 
              "https://doi.org/10.1038/nn1455"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.72", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002856506", 
              "https://doi.org/10.1038/npp.2010.72"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-002-1224-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028857651", 
              "https://doi.org/10.1007/s00213-002-1224-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/pl00005490", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1022406988", 
              "https://doi.org/10.1007/pl00005490"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-007-0891-z", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1015613687", 
              "https://doi.org/10.1007/s00213-007-0891-z"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130050952", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000228022", 
              "https://doi.org/10.1007/s002130050952"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.2165/00003495-200767010-00004", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1051517934", 
              "https://doi.org/10.2165/00003495-200767010-00004"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/978-3-540-69248-5_11", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1004262903", 
              "https://doi.org/10.1007/978-3-540-69248-5_11"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-002-1154-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000358774", 
              "https://doi.org/10.1007/s00213-002-1154-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-011-2296-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1011246983", 
              "https://doi.org/10.1007/s00213-011-2296-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-007-0802-3", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1000536090", 
              "https://doi.org/10.1007/s00213-007-0802-3"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2010.240", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1028027444", 
              "https://doi.org/10.1038/npp.2010.240"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-009-1739-5", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1019078218", 
              "https://doi.org/10.1007/s00213-009-1739-5"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002130100801", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1006122751", 
              "https://doi.org/10.1007/s002130100801"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/clpt.2011.20", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1002125104", 
              "https://doi.org/10.1038/clpt.2011.20"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/nn1452", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1049879652", 
              "https://doi.org/10.1038/nn1452"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/npp.2009.29", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1017994421", 
              "https://doi.org/10.1038/npp.2009.29"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-007-0916-7", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1012546843", 
              "https://doi.org/10.1007/s00213-007-0916-7"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/bf02245149", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1035909322", 
              "https://doi.org/10.1007/bf02245149"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.npp.1301509", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1037551233", 
              "https://doi.org/10.1038/sj.npp.1301509"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00213-006-0529-6", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050131424", 
              "https://doi.org/10.1007/s00213-006-0529-6"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2011-12-21", 
        "datePublishedReg": "2011-12-21", 
        "description": "Lorcaserin ((1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine HCl) is a selective 5-HT2C receptor agonist with clinical efficacy in phase-III obesity trials. Based on evidence that this drug class also affects behaviors motivated by drug reinforcement, we compared the effect of lorcaserin on behavior maintained by food and nicotine reinforcement, as well as the stimulant and discriminative stimulus properties of nicotine in the rat. Acutely administered lorcaserin (0.3\u20133\u2009mg/kg, subcutaneous (SC)) dose dependently reduced feeding induced by 22-h food deprivation or palatability. Effects up to 1\u2009mg/kg were consistent with a specific effect on feeding motivation. Lorcaserin (0.6\u20131\u2009mg/kg, SC) reduced operant responding for food on progressive and fixed ratio schedules of reinforcement. In this dose range lorcaserin also reversed the motor stimulant effect of nicotine, reduced intravenous self-administration of nicotine, and attenuated the nicotine cue in rats trained to discriminate nicotine from saline. Lorcaserin also reduced the reinstatement of nicotine-seeking behavior elicited by a compound cue comprising a nicotine prime and conditioned stimulus previously paired with nicotine reinforcement. Lorcaserin did not reinstate nicotine-seeking behavior or substitute for a nicotine cue. Finally, lorcaserin (0.3\u20131\u2009mg/kg) reduced nicotine-induced increases in anticipatory responding, a measure of impulsive action, in rats performing the five-choice serial reaction time task. Importantly, these results indicate that lorcaserin, and likely other selective 5-HT2C receptor agonists, similarly affect both food- and nicotine-motivated behaviors, and nicotine-induced impulsivity. Collectively, these findings highlight a therapeutic potential for 5-HT2C agonists such as lorcaserin beyond obesity into addictive behaviors, such as nicotine dependence.", 
        "genre": "article", 
        "id": "sg:pub.10.1038/npp.2011.303", 
        "isAccessibleForFree": true, 
        "isPartOf": [
          {
            "id": "sg:journal.1099176", 
            "issn": [
              "0893-133X", 
              "1740-634X"
            ], 
            "name": "Neuropsychopharmacology", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "5", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "37"
          }
        ], 
        "keywords": [
          "nicotine-seeking behavior", 
          "nicotine cue", 
          "five-choice serial reaction time task", 
          "serial reaction time task", 
          "reaction time task", 
          "nicotine reinforcement", 
          "nicotine-motivated behaviors", 
          "anticipatory responding", 
          "Nicotine Self-Administration", 
          "compound cue", 
          "time task", 
          "nicotine prime", 
          "impulsive action", 
          "addictive behaviors", 
          "impulse control", 
          "stimulus properties", 
          "lorcaserin dose", 
          "receptor agonist", 
          "drug reinforcement", 
          "effects of lorcaserin", 
          "cues", 
          "nicotine-induced increases", 
          "nicotine dependence", 
          "motor stimulant effects", 
          "ratio schedule", 
          "reinstatement", 
          "Self-Administration", 
          "agonist lorcaserin", 
          "clinical efficacy", 
          "fixed ratio schedule", 
          "drug classes", 
          "obesity trials", 
          "feeding motivation", 
          "stimulant effects", 
          "lorcaserin", 
          "therapeutic potential", 
          "nicotine", 
          "impulsivity", 
          "agonists", 
          "rats", 
          "specific effects", 
          "responding", 
          "food deprivation", 
          "behavior", 
          "stimuli", 
          "motivation", 
          "reinforcement", 
          "task", 
          "primes", 
          "discrimination", 
          "feeding behavior", 
          "measures", 
          "obesity", 
          "food", 
          "dose", 
          "findings", 
          "trials", 
          "saline", 
          "efficacy", 
          "relationship", 
          "deprivation", 
          "effect", 
          "feeding", 
          "evidence", 
          "action", 
          "schedule", 
          "control", 
          "increase", 
          "palatability", 
          "results", 
          "substitute", 
          "potential", 
          "class", 
          "dependence", 
          "properties"
        ], 
        "name": "The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control", 
        "pagination": "1177-1191", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1038645859"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1038/npp.2011.303"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "22189292"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1038/npp.2011.303", 
          "https://app.dimensions.ai/details/publication/pub.1038645859"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2022-10-01T06:37", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20221001/entities/gbq_results/article/article_545.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1038/npp.2011.303"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/npp.2011.303'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/npp.2011.303'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/npp.2011.303'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/npp.2011.303'


     

    This table displays all metadata directly associated to this object as RDF triples.

    379 TRIPLES      21 PREDICATES      148 URIs      117 LITERALS      32 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1038/npp.2011.303 schema:about N066aafb2d2db4456addd2d21b6c50067
    2 N33728cdffa18420d9de24a6b80799ee5
    3 N33f7576f87fd4c62af08dfc56358b8e0
    4 N4de8b11fa36040d69eba9948603db192
    5 N6305582b3daa409e9232373d618285a6
    6 N641cc283aabb46fd9bc42ebd35cb290a
    7 N65f05fc09c39484f93ae82e14a8d57dd
    8 N6a429348b8dd4cf88221a73e635bcbba
    9 N71b47f2146ff408795f4ec70f2863d44
    10 N74137085a0d140418470153e9d0ed7b2
    11 N851ece99d23a49edbeba7436055705eb
    12 N8735fc0c45924db99272ae85f4fcd632
    13 N87bfb3a4400e4ae3bff99e584509ac32
    14 N9709880b79ac499aad3306f2dfc3a7f8
    15 N9d2bca8f278745a1bc7e5af64798d076
    16 Naaf1564af4b84cbea91d092a1b808650
    17 Nab35a01c006745998b1b89b734a59e91
    18 Nb145a076a2e94e549f5773d0a65763ba
    19 Nc10591094ed94add80b26bec17f2df59
    20 Nd9b6c4a9f5534f37898e43b710b4d828
    21 Ndb057ae059e547c4a073538e19b18d01
    22 Ne481ff71b8ad4f18941c77c97e9c6e29
    23 Nf16f04e594254c84acfe9e9e037a741e
    24 Nf6e0abc158a644bf8f23fe095085586d
    25 Nfaeafb114bf640bcb569e76ccbb89dfb
    26 anzsrc-for:17
    27 anzsrc-for:1701
    28 schema:author N3021e1b1159f4762b5fb3c3e2f7eaf79
    29 schema:citation sg:pub.10.1007/978-3-540-69248-5_11
    30 sg:pub.10.1007/bf02245149
    31 sg:pub.10.1007/pl00005490
    32 sg:pub.10.1007/s00213-002-1154-7
    33 sg:pub.10.1007/s00213-002-1224-x
    34 sg:pub.10.1007/s00213-003-1426-x
    35 sg:pub.10.1007/s00213-006-0529-6
    36 sg:pub.10.1007/s00213-007-0802-3
    37 sg:pub.10.1007/s00213-007-0891-z
    38 sg:pub.10.1007/s00213-007-0916-7
    39 sg:pub.10.1007/s00213-009-1739-5
    40 sg:pub.10.1007/s00213-011-2296-2
    41 sg:pub.10.1007/s002130000504
    42 sg:pub.10.1007/s002130050952
    43 sg:pub.10.1007/s002130100801
    44 sg:pub.10.1038/clpt.2011.20
    45 sg:pub.10.1038/nn1452
    46 sg:pub.10.1038/nn1455
    47 sg:pub.10.1038/npp.2009.29
    48 sg:pub.10.1038/npp.2010.240
    49 sg:pub.10.1038/npp.2010.72
    50 sg:pub.10.1038/sj.npp.1301509
    51 sg:pub.10.2165/00003495-200767010-00004
    52 schema:datePublished 2011-12-21
    53 schema:datePublishedReg 2011-12-21
    54 schema:description Lorcaserin ((1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine HCl) is a selective 5-HT2C receptor agonist with clinical efficacy in phase-III obesity trials. Based on evidence that this drug class also affects behaviors motivated by drug reinforcement, we compared the effect of lorcaserin on behavior maintained by food and nicotine reinforcement, as well as the stimulant and discriminative stimulus properties of nicotine in the rat. Acutely administered lorcaserin (0.3–3 mg/kg, subcutaneous (SC)) dose dependently reduced feeding induced by 22-h food deprivation or palatability. Effects up to 1 mg/kg were consistent with a specific effect on feeding motivation. Lorcaserin (0.6–1 mg/kg, SC) reduced operant responding for food on progressive and fixed ratio schedules of reinforcement. In this dose range lorcaserin also reversed the motor stimulant effect of nicotine, reduced intravenous self-administration of nicotine, and attenuated the nicotine cue in rats trained to discriminate nicotine from saline. Lorcaserin also reduced the reinstatement of nicotine-seeking behavior elicited by a compound cue comprising a nicotine prime and conditioned stimulus previously paired with nicotine reinforcement. Lorcaserin did not reinstate nicotine-seeking behavior or substitute for a nicotine cue. Finally, lorcaserin (0.3–1 mg/kg) reduced nicotine-induced increases in anticipatory responding, a measure of impulsive action, in rats performing the five-choice serial reaction time task. Importantly, these results indicate that lorcaserin, and likely other selective 5-HT2C receptor agonists, similarly affect both food- and nicotine-motivated behaviors, and nicotine-induced impulsivity. Collectively, these findings highlight a therapeutic potential for 5-HT2C agonists such as lorcaserin beyond obesity into addictive behaviors, such as nicotine dependence.
    55 schema:genre article
    56 schema:isAccessibleForFree true
    57 schema:isPartOf N4ad8ef82ca6649beba5f475b75c7e9a7
    58 N8c48d5e2bee9412bb2b21d2f6aa62a6e
    59 sg:journal.1099176
    60 schema:keywords Nicotine Self-Administration
    61 Self-Administration
    62 action
    63 addictive behaviors
    64 agonist lorcaserin
    65 agonists
    66 anticipatory responding
    67 behavior
    68 class
    69 clinical efficacy
    70 compound cue
    71 control
    72 cues
    73 dependence
    74 deprivation
    75 discrimination
    76 dose
    77 drug classes
    78 drug reinforcement
    79 effect
    80 effects of lorcaserin
    81 efficacy
    82 evidence
    83 feeding
    84 feeding behavior
    85 feeding motivation
    86 findings
    87 five-choice serial reaction time task
    88 fixed ratio schedule
    89 food
    90 food deprivation
    91 impulse control
    92 impulsive action
    93 impulsivity
    94 increase
    95 lorcaserin
    96 lorcaserin dose
    97 measures
    98 motivation
    99 motor stimulant effects
    100 nicotine
    101 nicotine cue
    102 nicotine dependence
    103 nicotine prime
    104 nicotine reinforcement
    105 nicotine-induced increases
    106 nicotine-motivated behaviors
    107 nicotine-seeking behavior
    108 obesity
    109 obesity trials
    110 palatability
    111 potential
    112 primes
    113 properties
    114 ratio schedule
    115 rats
    116 reaction time task
    117 receptor agonist
    118 reinforcement
    119 reinstatement
    120 relationship
    121 responding
    122 results
    123 saline
    124 schedule
    125 serial reaction time task
    126 specific effects
    127 stimulant effects
    128 stimuli
    129 stimulus properties
    130 substitute
    131 task
    132 therapeutic potential
    133 time task
    134 trials
    135 schema:name The 5-HT2C Receptor Agonist Lorcaserin Reduces Nicotine Self-Administration, Discrimination, and Reinstatement: Relationship to Feeding Behavior and Impulse Control
    136 schema:pagination 1177-1191
    137 schema:productId N08f6e8b39edd4702806c3e80c7399e02
    138 N4f0e4bfc5cc449438c3e2336d32110c8
    139 N58e3236ed0124507975eacd6e26f2fd0
    140 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038645859
    141 https://doi.org/10.1038/npp.2011.303
    142 schema:sdDatePublished 2022-10-01T06:37
    143 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    144 schema:sdPublisher N169ef278bea341198e4ee0e944331125
    145 schema:url https://doi.org/10.1038/npp.2011.303
    146 sgo:license sg:explorer/license/
    147 sgo:sdDataset articles
    148 rdf:type schema:ScholarlyArticle
    149 N066aafb2d2db4456addd2d21b6c50067 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Nicotine
    151 rdf:type schema:DefinedTerm
    152 N08f6e8b39edd4702806c3e80c7399e02 schema:name doi
    153 schema:value 10.1038/npp.2011.303
    154 rdf:type schema:PropertyValue
    155 N0a977029a3b440f99c9dad82f8a1d756 schema:affiliation grid-institutes:None
    156 schema:familyName Roßmann
    157 schema:givenName Anne
    158 rdf:type schema:Person
    159 N169ef278bea341198e4ee0e944331125 schema:name Springer Nature - SN SciGraph project
    160 rdf:type schema:Organization
    161 N3021e1b1159f4762b5fb3c3e2f7eaf79 rdf:first sg:person.01347147473.36
    162 rdf:rest N5405751b9f3b4dfba78dfa75aa9f9bec
    163 N33728cdffa18420d9de24a6b80799ee5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    164 schema:name Serotonin Receptor Agonists
    165 rdf:type schema:DefinedTerm
    166 N33f7576f87fd4c62af08dfc56358b8e0 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    167 schema:name Rats
    168 rdf:type schema:DefinedTerm
    169 N4ad8ef82ca6649beba5f475b75c7e9a7 schema:volumeNumber 37
    170 rdf:type schema:PublicationVolume
    171 N4de8b11fa36040d69eba9948603db192 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    172 schema:name Dose-Response Relationship, Drug
    173 rdf:type schema:DefinedTerm
    174 N4f0e4bfc5cc449438c3e2336d32110c8 schema:name pubmed_id
    175 schema:value 22189292
    176 rdf:type schema:PropertyValue
    177 N5405751b9f3b4dfba78dfa75aa9f9bec rdf:first sg:person.01254103027.51
    178 rdf:rest Nc90387a66ec6480e94ffd5776eb4421e
    179 N58e3236ed0124507975eacd6e26f2fd0 schema:name dimensions_id
    180 schema:value pub.1038645859
    181 rdf:type schema:PropertyValue
    182 N5d126e35a6484454923c33047390630a rdf:first sg:person.01075705567.20
    183 rdf:rest Nbde13852b8044acaa266de5a981c72c1
    184 N61c3a2a838b048f4b0ddeaacdf7f9cb1 rdf:first sg:person.01147665155.39
    185 rdf:rest N7e94ee5702d2454785fcfb894a899928
    186 N6305582b3daa409e9232373d618285a6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    187 schema:name Animals
    188 rdf:type schema:DefinedTerm
    189 N641cc283aabb46fd9bc42ebd35cb290a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    190 schema:name Feeding Behavior
    191 rdf:type schema:DefinedTerm
    192 N65f05fc09c39484f93ae82e14a8d57dd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    193 schema:name Self Administration
    194 rdf:type schema:DefinedTerm
    195 N6a429348b8dd4cf88221a73e635bcbba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    196 schema:name Drug Administration Routes
    197 rdf:type schema:DefinedTerm
    198 N71b47f2146ff408795f4ec70f2863d44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    199 schema:name Impulsive Behavior
    200 rdf:type schema:DefinedTerm
    201 N74137085a0d140418470153e9d0ed7b2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    202 schema:name Analysis of Variance
    203 rdf:type schema:DefinedTerm
    204 N7e94ee5702d2454785fcfb894a899928 rdf:first sg:person.0761457167.61
    205 rdf:rest N5d126e35a6484454923c33047390630a
    206 N851ece99d23a49edbeba7436055705eb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    207 schema:name Reinforcement, Psychology
    208 rdf:type schema:DefinedTerm
    209 N8735fc0c45924db99272ae85f4fcd632 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    210 schema:name Discrimination, Psychological
    211 rdf:type schema:DefinedTerm
    212 N87bfb3a4400e4ae3bff99e584509ac32 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    213 schema:name Nicotinic Agonists
    214 rdf:type schema:DefinedTerm
    215 N8c48d5e2bee9412bb2b21d2f6aa62a6e schema:issueNumber 5
    216 rdf:type schema:PublicationIssue
    217 N9709880b79ac499aad3306f2dfc3a7f8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    218 schema:name Benzazepines
    219 rdf:type schema:DefinedTerm
    220 N9d2bca8f278745a1bc7e5af64798d076 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    221 schema:name Motor Activity
    222 rdf:type schema:DefinedTerm
    223 Naaf1564af4b84cbea91d092a1b808650 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    224 schema:name Conditioning, Operant
    225 rdf:type schema:DefinedTerm
    226 Nab35a01c006745998b1b89b734a59e91 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    227 schema:name Aminopyridines
    228 rdf:type schema:DefinedTerm
    229 Nb145a076a2e94e549f5773d0a65763ba schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    230 schema:name Indoles
    231 rdf:type schema:DefinedTerm
    232 Nbde13852b8044acaa266de5a981c72c1 rdf:first sg:person.07504427742.08
    233 rdf:rest rdf:nil
    234 Nc10591094ed94add80b26bec17f2df59 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    235 schema:name Behavior, Animal
    236 rdf:type schema:DefinedTerm
    237 Nc90387a66ec6480e94ffd5776eb4421e rdf:first N0a977029a3b440f99c9dad82f8a1d756
    238 rdf:rest N61c3a2a838b048f4b0ddeaacdf7f9cb1
    239 Nd9b6c4a9f5534f37898e43b710b4d828 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    240 schema:name Eating
    241 rdf:type schema:DefinedTerm
    242 Ndb057ae059e547c4a073538e19b18d01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    243 schema:name Male
    244 rdf:type schema:DefinedTerm
    245 Ne481ff71b8ad4f18941c77c97e9c6e29 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    246 schema:name Rats, Sprague-Dawley
    247 rdf:type schema:DefinedTerm
    248 Nf16f04e594254c84acfe9e9e037a741e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    249 schema:name Rotarod Performance Test
    250 rdf:type schema:DefinedTerm
    251 Nf6e0abc158a644bf8f23fe095085586d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    252 schema:name Reaction Time
    253 rdf:type schema:DefinedTerm
    254 Nfaeafb114bf640bcb569e76ccbb89dfb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    255 schema:name Choice Behavior
    256 rdf:type schema:DefinedTerm
    257 anzsrc-for:17 schema:inDefinedTermSet anzsrc-for:
    258 schema:name Psychology and Cognitive Sciences
    259 rdf:type schema:DefinedTerm
    260 anzsrc-for:1701 schema:inDefinedTermSet anzsrc-for:
    261 schema:name Psychology
    262 rdf:type schema:DefinedTerm
    263 sg:journal.1099176 schema:issn 0893-133X
    264 1740-634X
    265 schema:name Neuropsychopharmacology
    266 schema:publisher Springer Nature
    267 rdf:type schema:Periodical
    268 sg:person.01075705567.20 schema:affiliation grid-institutes:grid.155956.b
    269 schema:familyName Soko
    270 schema:givenName Ashlie D
    271 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01075705567.20
    272 rdf:type schema:Person
    273 sg:person.01147665155.39 schema:affiliation grid-institutes:grid.155956.b
    274 schema:familyName Rizos
    275 schema:givenName Zoe
    276 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01147665155.39
    277 rdf:type schema:Person
    278 sg:person.01254103027.51 schema:affiliation grid-institutes:None
    279 schema:familyName Silenieks
    280 schema:givenName Leo B
    281 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01254103027.51
    282 rdf:type schema:Person
    283 sg:person.01347147473.36 schema:affiliation grid-institutes:grid.17063.33
    284 schema:familyName Higgins
    285 schema:givenName Guy A
    286 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01347147473.36
    287 rdf:type schema:Person
    288 sg:person.07504427742.08 schema:affiliation grid-institutes:grid.17063.33
    289 schema:familyName Fletcher
    290 schema:givenName Paul J
    291 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07504427742.08
    292 rdf:type schema:Person
    293 sg:person.0761457167.61 schema:affiliation grid-institutes:grid.155956.b
    294 schema:familyName Noble
    295 schema:givenName Kevin
    296 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761457167.61
    297 rdf:type schema:Person
    298 sg:pub.10.1007/978-3-540-69248-5_11 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004262903
    299 https://doi.org/10.1007/978-3-540-69248-5_11
    300 rdf:type schema:CreativeWork
    301 sg:pub.10.1007/bf02245149 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035909322
    302 https://doi.org/10.1007/bf02245149
    303 rdf:type schema:CreativeWork
    304 sg:pub.10.1007/pl00005490 schema:sameAs https://app.dimensions.ai/details/publication/pub.1022406988
    305 https://doi.org/10.1007/pl00005490
    306 rdf:type schema:CreativeWork
    307 sg:pub.10.1007/s00213-002-1154-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000358774
    308 https://doi.org/10.1007/s00213-002-1154-7
    309 rdf:type schema:CreativeWork
    310 sg:pub.10.1007/s00213-002-1224-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1028857651
    311 https://doi.org/10.1007/s00213-002-1224-x
    312 rdf:type schema:CreativeWork
    313 sg:pub.10.1007/s00213-003-1426-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1014431196
    314 https://doi.org/10.1007/s00213-003-1426-x
    315 rdf:type schema:CreativeWork
    316 sg:pub.10.1007/s00213-006-0529-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050131424
    317 https://doi.org/10.1007/s00213-006-0529-6
    318 rdf:type schema:CreativeWork
    319 sg:pub.10.1007/s00213-007-0802-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000536090
    320 https://doi.org/10.1007/s00213-007-0802-3
    321 rdf:type schema:CreativeWork
    322 sg:pub.10.1007/s00213-007-0891-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1015613687
    323 https://doi.org/10.1007/s00213-007-0891-z
    324 rdf:type schema:CreativeWork
    325 sg:pub.10.1007/s00213-007-0916-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012546843
    326 https://doi.org/10.1007/s00213-007-0916-7
    327 rdf:type schema:CreativeWork
    328 sg:pub.10.1007/s00213-009-1739-5 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019078218
    329 https://doi.org/10.1007/s00213-009-1739-5
    330 rdf:type schema:CreativeWork
    331 sg:pub.10.1007/s00213-011-2296-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011246983
    332 https://doi.org/10.1007/s00213-011-2296-2
    333 rdf:type schema:CreativeWork
    334 sg:pub.10.1007/s002130000504 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050140339
    335 https://doi.org/10.1007/s002130000504
    336 rdf:type schema:CreativeWork
    337 sg:pub.10.1007/s002130050952 schema:sameAs https://app.dimensions.ai/details/publication/pub.1000228022
    338 https://doi.org/10.1007/s002130050952
    339 rdf:type schema:CreativeWork
    340 sg:pub.10.1007/s002130100801 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006122751
    341 https://doi.org/10.1007/s002130100801
    342 rdf:type schema:CreativeWork
    343 sg:pub.10.1038/clpt.2011.20 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002125104
    344 https://doi.org/10.1038/clpt.2011.20
    345 rdf:type schema:CreativeWork
    346 sg:pub.10.1038/nn1452 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049879652
    347 https://doi.org/10.1038/nn1452
    348 rdf:type schema:CreativeWork
    349 sg:pub.10.1038/nn1455 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052352207
    350 https://doi.org/10.1038/nn1455
    351 rdf:type schema:CreativeWork
    352 sg:pub.10.1038/npp.2009.29 schema:sameAs https://app.dimensions.ai/details/publication/pub.1017994421
    353 https://doi.org/10.1038/npp.2009.29
    354 rdf:type schema:CreativeWork
    355 sg:pub.10.1038/npp.2010.240 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028027444
    356 https://doi.org/10.1038/npp.2010.240
    357 rdf:type schema:CreativeWork
    358 sg:pub.10.1038/npp.2010.72 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002856506
    359 https://doi.org/10.1038/npp.2010.72
    360 rdf:type schema:CreativeWork
    361 sg:pub.10.1038/sj.npp.1301509 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037551233
    362 https://doi.org/10.1038/sj.npp.1301509
    363 rdf:type schema:CreativeWork
    364 sg:pub.10.2165/00003495-200767010-00004 schema:sameAs https://app.dimensions.ai/details/publication/pub.1051517934
    365 https://doi.org/10.2165/00003495-200767010-00004
    366 rdf:type schema:CreativeWork
    367 grid-institutes:None schema:alternateName InterVivo Solutions Inc., Toronto, ON, Canada
    368 schema:name InterVivo Solutions Inc., Toronto, ON, Canada
    369 rdf:type schema:Organization
    370 grid-institutes:grid.155956.b schema:alternateName Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada
    371 schema:name Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada
    372 rdf:type schema:Organization
    373 grid-institutes:grid.17063.33 schema:alternateName Department Pharmacology, University of Toronto, Toronto, ON, Canada
    374 Department Psychiatry & Psychology, University of Toronto, Toronto, ON, Canada
    375 schema:name Clarke Division, Section of Biopsychology, Centre for Addiction and Mental Health, Toronto, ON, Canada
    376 Department Pharmacology, University of Toronto, Toronto, ON, Canada
    377 Department Psychiatry & Psychology, University of Toronto, Toronto, ON, Canada
    378 InterVivo Solutions Inc., Toronto, ON, Canada
    379 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...